ELUCIREM sol inj 0.5 mmol/ml 7.5ml ser pré
7680687910019
CH-68791
V08CA12
14.02.0.
Reimbursement limitations:
ELUCIREM
ELUCIREM est remboursé dans toutes les indications exclusivement à une dose de 0.05 mmol/kg de …
bing
Details
- Product number
- 6879101
- CPT
- -
- Packaging group
- 7,5
- Unit
- ml
- Composition
- gadopiclenolum 485.1 mg corresp. 0.5 mmol corresp. gadolinium 78.6 mg, tetraxetanum, trometamolum, natrii hydroxidum aut acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.46 mg.
Articles (1)
Elucirem 0.5 mmol/ml, Injektionslösung in einer Fertigspritze
Injektionslösung
7,5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
485.1 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
78.6 MG | Substance | WIIS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.46 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 84.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2025
Authorization holder
Guerbet AG
8050 Zürich
Authorization information
- Swissmedic authorization number
- 68791
- Drug name
- Elucirem, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- V08CA12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 21/12/2023
- Authorization expiration date
- 20/12/2028
- IT number
- 14.02.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ELUCIREM sol inj 0.5 mmol/ml 7.5ml ser pré
- Description (DE)
- ELUCIREM Inj Lös 0.5 mmol/ml 7.5ml Fertspr
- Market launch
- 21/12/2023
- Narcotic (BTM)
- No